What is CiiTECH?
Founded in 2017, CiiTECH operates within the cannabis biotech sector, focusing on the discovery, development, and commercialization of therapeutic cannabis products. The company capitalizes on Israel's advanced cannabis innovation ecosystem through collaborations with leading research institutions. CiiTECH also partners with local suppliers in the UK and Europe, facilitating the overseas availability of Israeli cannabis products via its UK-based eCommerce platform.
How much funding has CiiTECH raised?
CiiTECH has raised a total of $241K across 1 funding round:
Private Equity
$241K
Private Equity (2021): $241K with participation from FastForward Innovations
Key Investors in CiiTECH
FastForward Innovations
FastForward Innovations Limited is an investment firm focused on funding innovative solutions for future markets. They specialize in identifying and backing unique opportunities across various sectors, providing insights and financial reports to potential investors interested in venture capital and innovation.
What's next for CiiTECH?
The large-scale, late-stage funding CiiTECH has attracted indicates a strong market validation and a strategic push towards scaling operations and expanding its therapeutic cannabis product pipeline. This capital infusion is expected to accelerate research and development initiatives, enhance its international market presence, and potentially lead to further strategic partnerships within the burgeoning global cannabis industry.
See full CiiTECH company page
